Top Biotechnology companies in Sweden by Return on Equity (ROE)

This ranking features the top 50 Biotechnology companies in Sweden ranked by Return on Equity (ROE), averaging a Return on Equity (ROE) of -28.47%, for February 04, 2025.

Sweden

Biotechnology

#	Name	Return on Equity (ROE)	Reported Date	Stock Price	Change	Country
1	Nanologica AB (publ) 1 NICA.ST	3,959.80%	Dec. 31, 2023	USD 0.19	-8.49%	Sweden
2	Hansa Biopharma AB (publ) 2 HNSA.ST	495.44%	Dec. 31, 2023	USD 3.01	-2.55%	Sweden
3	Bonesupport Holding AB (publ) 3 BONEX.ST	44.94%	Dec. 31, 2023	USD 30.85	-1.29%	Sweden
4	Genovis AB (publ.) 4 GENO.ST	32.23%	Dec. 31, 2023	USD 2.25	-17.68%	Sweden
5	Camurus AB (publ) 5 CAMX.ST	28.90%	Dec. 31, 2023	USD 52.33	-2.11%	Sweden
6	BioArctic AB (publ) 6 BIOA-B.ST	21.90%	Dec. 31, 2023	USD 18.98	-4.07%	Sweden
7	CellaVision AB (publ) 7 CEVI.ST	18.19%	Dec. 31, 2023	USD 19.20	-5.48%	Sweden
8	BioGaia AB (publ) 8 BIOG-B.ST	17.99%	Dec. 31, 2023	USD 10.71	-1.60%	Sweden
9	ADDvise Group AB (publ) 9 ADDV-B.ST	16.88%	Dec. 31, 2023	USD 0.21	-4.72%	Sweden
10	C-Rad AB (publ) 10 CRAD-B.ST	13.10%	Dec. 31, 2023	USD 2.87	-1.57%	Sweden
11	Elekta AB (publ) 11 EKTA-B.ST	12.08%	April 30, 2024	USD 5.73	-2.84%	Sweden
12	RaySearch Laboratories AB (publ) 12 RAY-B.ST	11.09%	Dec. 31, 2023	USD 21.91	3.49%	Sweden
13	Magle Chemoswed Holding AB (publ) 13 MAGLE.ST	7.69%	Dec. 31, 2023	USD 2.77	-4.78%	Sweden
14	Swedish Orphan Biovitrum AB (publ) 14 SOBI.ST	7.11%	Dec. 31, 2023	USD 29.22	-3.00%	Sweden
15	Biotage AB (publ) 15 BIOT.ST	6.73%	Dec. 31, 2023	USD 12.37	-2.86%	Sweden
16	Arjo AB (publ) 16 ARJO-B.ST	6.33%	Dec. 31, 2023	USD 3.53	-1.01%	Sweden
17	Arcoma AB 17 ARCOMA.ST	5.27%	Dec. 31, 2023	USD 0.94	-2.04%	Sweden
18	Boule Diagnostics AB (publ) 18 BOUL.ST	5.26%	Dec. 31, 2023	USD 0.79	-7.19%	Sweden
19	Getinge AB (publ) 19 GETI-B.ST	4.96%	Dec. 31, 2024	USD 19.03	-2.75%	Sweden
20	Xvivo Perfusion AB (publ) 20 XVIVO.ST	4.72%	Dec. 31, 2023	USD 41.47	-0.80%	Sweden
21	AddLife AB (publ) 21 ALIF-B.ST	3.83%	Dec. 31, 2023	USD 13.28	-2.29%	Sweden
22	Medicover AB (publ) 22 MCOV-B.ST	3.54%	Dec. 31, 2023	USD 18.49	0.08%	Sweden
23	Integrum AB (publ) 23 INTEG-B.ST	2.82%	April 30, 2024	USD 1.57	-5.13%	Sweden
24	Vimian Group AB (publ) 24 VIMIAN.ST	1.87%	Dec. 31, 2023	USD 3.55	-2.70%	Sweden
25	Probi AB (publ) 25 PROB.ST	1.23%	Dec. 31, 2023	USD 31.05	0.32%	Sweden
26	Mentice AB (publ) 26 MNTC.ST	-1.77%	Dec. 31, 2023	USD 2.27	-2.64%	Sweden
27	Moberg Pharma AB (publ) 27 MOB.ST	-3.45%	Dec. 31, 2023	USD 0.85	-1.32%	Sweden
28	Sedana Medical AB (publ) 28 SEDANA.ST	-6.15%	Dec. 31, 2023	USD 1.59	-2.74%	Sweden
29	Devyser Diagnostics AB (publ) 29 DVYSR.ST	-13.92%	Dec. 31, 2023	USD 11.62	0.33%	Sweden
30	Mendus AB (publ) 30 IMMU.ST	-14.42%	Dec. 31, 2023	USD 0.71	8.98%	Sweden
31	SpectraCure AB (publ) 31 SPEC.ST	-15.74%	Dec. 31, 2023	USD 0.18	-3.03%	Sweden
32	BioInvent International AB (publ) 32 BINV.ST	-25.22%	Dec. 31, 2023	USD 2.43	-5.44%	Sweden
33	Xspray Pharma AB (publ) 33 XSPRAY.ST	-25.91%	Dec. 31, 2023	USD 3.06	1.23%	Sweden
34	Vitrolife AB (publ) 34 VITR.ST	-30.27%	Dec. 31, 2023	USD 19.80	-1.20%	Sweden
35	SenzaGen AB 35 SENZA.ST	-32.68%	Dec. 31, 2023	USD 0.62	-5.18%	Sweden
36	Bactiguard Holding AB (publ) 36 BACTI-B.ST	-39.18%	Dec. 31, 2023	USD 3.10	-2.79%	Sweden
37	Iconovo AB (publ) 37 ICO.ST	-40.43%	Dec. 31, 2023	USD 0.39	-4.99%	Sweden
38	OssDsign AB (publ) 38 OSSD.ST	-51.96%	Dec. 31, 2023	USD 0.96	3.49%	Sweden
39	Egetis Therapeutics AB (publ) 39 EGTX.ST	-59.92%	Dec. 31, 2023	USD 0.54	-2.24%	Sweden
40	Enzymatica AB (publ) 40 ENZY.ST	-64.91%	Dec. 31, 2023	USD 0.13	0.88%	Sweden
41	Diamyd Medical AB (publ) 41 DMYD-B.ST	-68.52%	Aug. 31, 2023	USD 1.49	-4.08%	Sweden
42	Nanexa AB (publ) 42 NANEXA.ST	-79.72%	Dec. 31, 2023	USD 0.13	-9.77%	Sweden
43	Ortivus AB (publ) 43 ORTI-B.ST	-105.43%	Dec. 31, 2023	USD 0.16	-2.74%	Sweden
44	SynAct Pharma AB 44 SYNACT.ST	-122.49%	Dec. 31, 2023	USD 1.26	-1.32%	Sweden
45	Biovica International AB (publ) 45 BIOVIC-B.ST	-129.16%	April 30, 2024	USD 0.18	-8.41%	Sweden
46	Prostatype Genomics AB (publ) 46 PROGEN.ST	-167.93%	Dec. 31, 2023	USD 0.76	-6.55%	Sweden
47	Clinical Laserthermia Systems AB (publ) 47 CLS-B.ST	-174.34%	Dec. 31, 2023	USD 0.35	-1.61%	Sweden
48	Orexo AB (publ) 48 ORX.ST	-217.83%	Dec. 31, 2023	USD 1.64	-3.31%	Sweden
49	Dignitana AB (publ) 49 DIGN.ST	-239.03%	Dec. 31, 2023	USD 0.10	-5.24%	Sweden
50	Oncopeptides AB (publ) 50 ONCO.ST	-438.73%	Dec. 31, 2023	USD 0.16	9.53%	Sweden

Frequently Asked Questions

Which Biotechnology company in Sweden has the highest Return on Equity (ROE) ?

The Biotechnology company in Sweden with the highest Return on Equity (ROE) is Nanologica AB (publ) (Stockholm Stock Exchange: NICA.ST) at 3,959.80%.
Which Biotechnology company in Sweden has the lowest Return on Equity (ROE) ?

The Biotechnology company in Sweden with the lowest Return on Equity (ROE) is Oncopeptides AB (publ) (Stockholm Stock Exchange: ONCO.ST) at -438.73%.

What are the top 10 Biotechnology companies in Sweden by Return on Equity (ROE) ?

The top 10 Biotechnology companies in Sweden by Return on Equity (ROE) are Nanologica AB (publ), Hansa Biopharma AB (publ), Bonesupport Holding AB (publ), Genovis AB (publ.), Camurus AB (publ), BioArctic AB (publ), CellaVision AB (publ), BioGaia AB (publ), ADDvise Group AB (publ) and C-Rad AB (publ).
What are the bottom 10 Biotechnology companies in Sweden by Return on Equity (ROE) ?

The bottom 10 Biotechnology companies in Sweden by Return on Equity (ROE) are Oncopeptides AB (publ), Dignitana AB (publ), Orexo AB (publ), Clinical Laserthermia Systems AB (publ), Prostatype Genomics AB (publ), Biovica International AB (publ), SynAct Pharma AB, Ortivus AB (publ), Nanexa AB (publ) and Diamyd Medical AB (publ).

Frequently Asked Questions

Don’t Miss A Beat